Literature DB >> 25271189

A multi-disciplinary model of risk factors for fatal outcome in posterior reversible encephalopathy syndrome.

Lea M Alhilali1, Arich R Reynolds2, Saeed Fakhran3.   

Abstract

PURPOSE: To evaluate the relative impact of clinical data, imaging findings, and CSF laboratory values on clinical outcome in patients with posterior reversible encephalopathy syndrome (PRES).
METHODS: 47 patients with PRES who underwent a lumbar puncture were retrospectively evaluated. Fatal outcome was defined as death directly ascribed to PRES toxicity. Univariate and multivariate analyses were used to evaluate the association between fatal outcome and clinical factors (demographics, PRES etiology), imaging findings (signal abnormality severity, atypical distribution, restricted diffusion, hemorrhage, enhancement, angiographic abnormalities), and lumbar puncture results (appearance, cell count, glucose, protein, culture results).
RESULTS: Nine patients (19.1%) had a fatal outcome. Odds of a fatal outcome increased nearly 5-fold with hemorrhage on imaging (Adjusted Odds Ratio (AOR) 4.8, 95% CI 3.8-6.0, p=0.03) and nearly doubled with low CSF glucose (AOR 1.9, 95% CI 1.5-2.5, p=0.02). Hypertensive encephalopathy as an etiology was associated with a fatal outcome (AOR 1.6, 95% CI 1.3-2.9, p=0.02), while toxemia of pregnancy was protective, with a 75% decreased risk (AOR 0.25, 95% CI 0.15-0.43, p=0.02).
CONCLUSION: Clinical, imaging, and CSF laboratory findings all influence outcome in PRES, with a low CSF glucose, hypertensive encephalopathy, and imaging findings of hemorrhage associated with increased risk of fatal outcome.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  CSF; Hypertension; Lumbar puncture; Magnetic resonance imaging; Microhemorrhage; Posterior reversible encephalopathy syndrome

Mesh:

Substances:

Year:  2014        PMID: 25271189     DOI: 10.1016/j.jns.2014.09.019

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Posterior reversible encephalopathy syndrome with colitis in a patient treated with panitumumab.

Authors:  Céline Blaye; Xavier Buy; Marine Gross-Goupil; Didier Vincent; Claire Jamet; Paul Sargos; Stéphane Culine; Guilhem Roubaud
Journal:  Ther Adv Drug Saf       Date:  2017-01-16

2.  Spectrum of cerebral spinal fluid findings in patients with posterior reversible encephalopathy syndrome.

Authors:  Lars Neeb; Jenneke Hoekstra; Matthias Endres; Bob Siegerink; Eberhard Siebert; Thomas G Liman
Journal:  J Neurol       Date:  2016-01       Impact factor: 4.849

3.  The Clinical Outcome of Posterior Reversible Encephalopathy Syndrome.

Authors:  B Gao; A Lerner; M Law
Journal:  AJNR Am J Neuroradiol       Date:  2016-06-30       Impact factor: 3.825

4.  Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome.

Authors:  Andrew D Schweitzer; Neal S Parikh; Gulce Askin; Ajay Nemade; John Lyo; Sasan Karimi; Anna Knobel; Babak B Navi; Robert J Young; Ajay Gupta
Journal:  Neuroradiology       Date:  2017-03-13       Impact factor: 2.804

5.  Factors associated with fatal outcome in posterior reversible encephalopathy syndrome: a retrospective analysis of the Berlin PRES study.

Authors:  Eberhard Siebert; G Bohner; T Liebig; M Endres; T G Liman
Journal:  J Neurol       Date:  2016-11-04       Impact factor: 4.849

6.  Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels.

Authors:  B Gao; B X Yu; R S Li; G Zhang; H Z Xie; F L Liu; C Lv
Journal:  AJNR Am J Neuroradiol       Date:  2015-07-02       Impact factor: 3.825

7.  Malignant Posterior Reversible Encephalopathy Syndrome-An Exacting Challenge for Neurocritical Care Physicians.

Authors:  Shahvaiz Magsi; Atif Zafar
Journal:  Neurohospitalist       Date:  2017-02-08

8.  Malignant Posterior Reversible Encephalopathy Syndrome: A Case of Posterior Irreversible Encephalopathy Syndrome.

Authors:  William Alves Martins; Luiz Carlos Porcello Marrone
Journal:  J Clin Neurol       Date:  2015-11-04       Impact factor: 3.077

9.  Cerebrospinal Fluid in Posterior Reversible Encephalopathy Syndrome: Implications of Elevated Protein and Pleocytosis.

Authors:  Colin A Ellis; Andrew C McClelland; Suyash Mohan; Emory Kuo; Scott E Kasner; Cen Zhang; Pouya Khankhanian; Ramani Balu
Journal:  Neurohospitalist       Date:  2018-09-27

10.  Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis.

Authors:  Zheng Chen; Gang Zhang; Alexander Lerner; An-Hui Wang; Bo Gao; Jie Liu
Journal:  Quant Imaging Med Surg       Date:  2018-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.